Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathwaysNoha Nabil Mohammed, Mina Y. George|Inflammopharmacology|2023Cited by 53